Abstract: Immune function of an animal can be modulated by administration of a composition that includes beta glucan. The beta glucan can be derived from Euglena, which provides a form of beta glucan that is different from other organisms, where the beta glucan is predominantly unbranched beta-(1,3)-glucan. Beta glucan can also be complexed with a metal, such as zinc, and/or can combined with an animal feed component to form an animal feed composition. Use of such compositions can improve the well being of an animal, and may augment or even replace the use of antibiotics in certain circumstances.
Type:
Grant
Filed:
March 1, 2019
Date of Patent:
December 22, 2020
Assignee:
KEMIN INDUSTRIES, INC.
Inventors:
Jeffrey Richard LeBrun, Robert Levine, Geoffrey Paul Horst
Abstract: Extracts of plants of the Lamiaceae family, including the Mentha genus, are shown to have a positive impact on overall cognitive health, including improvements in memory, reasoning, attention/concentration, planning, mood, sleep and associated behaviors.
Abstract: Immune function of a plant can be modulated by administering a composition comprising beta glucan, where the beta glucan includes unbranched beta-(1,3)-glucan. Such unbranched beta-(1,3)-glucan can be obtained from Euglena, including heterotrophically grown Euglena. The unbranched beta-(1,3)-glucan can be in the form of paramylon and/or can be part of algae meal. The composition can further include a fertilizer, a pesticide, a fungicide, a bactericide, combinations thereof, as well as one or more various plant immune system modulators other than beta glucan. The wellbeing of the plant seed, seedling, mature plant, or harvested plant product can accordingly be improved.
Type:
Grant
Filed:
October 11, 2018
Date of Patent:
September 29, 2020
Assignee:
KEMIN INDUSTRIES, INC.
Inventors:
Robert B. Levine, Geoffrey P. Horst, Jeffrey R. LeBrun
Abstract: Methods of administering a composition that comprises plant extracts selected from the group consisting of Quercus infectoria, Rhus chinensis and Terminalia chebula containing compounds such as gallic acid, derivative of gallic acid, gallotannins and hydrosable tannins, which have been found to control coccidiosis in poultry and, more specifically, coccidiosis caused by Eimeria spp. The plant extracts result in a reduction of lesion score, oocysts per gram of fecal matter and mortality.
Abstract: Natural plant parts and extracts of plants selected from the group consisting of Quercus infectoria, Rhus chinensis and Terminalia chebula containing compounds such as gallic acid, derivative of gallic acid, gallotannins and hydrolysable tannins have been found to control coccidiosis in poultry and, more specifically, coccidiosis caused by Eimeria spp. The plant parts and natural extracts result in a reduction of lesion score, oocysts per gram of fecal matter and mortality.
Abstract: The present invention is a water-soluble form of lipophilic molecules contained in liposomes. In one embodiment, the lipophilic molecule is crystalline lutein and the lutein-loaded liposomes are included in pharmaceutical products, medical devices, and dietary supplements industry, with potential for chewable tablets, fortification of beverages, effervescent tablets, uncoated tablets, nutritional bars, and functional foods in addition to cosmetic industry.
Abstract: Iontophoresis, a minimally-invasive methodology that uses a weak electric current to enhance penetration of ionized molecules into tissues, was found to be an effective technique for the intraocular delivery of large bioactive molecules, specifically lutein.
Type:
Grant
Filed:
December 21, 2015
Date of Patent:
June 25, 2019
Assignee:
KEMIN INDUSTRIES, INC.
Inventors:
Diogo de Sousa Martins, Pierre Roy, Giovanni Cavallo, Fulvio Foschini
Abstract: A method of improving intestinal integrity and reducing the effects of heat stress, enteric disease challenges and other intestinal stress conditions in humans and animals by feeding an efficacious amount of a salt of zinc and butyric acid.
Type:
Grant
Filed:
June 30, 2016
Date of Patent:
May 21, 2019
Assignee:
KEMIN INDUSTRIES, INC.
Inventors:
Venkatesh Mani, Jon Rubach, Mitchell Poss
Abstract: Immune function of an animal can be modulated by administration of a composition that includes beta glucan. The beta glucan can be derived from Euglena, which provides a form of beta glucan that is different from other organisms, where the beta glucan is predominantly unbranched beta-(1,3)-glucan. Beta glucan can also be complexed with a metal, such as zinc, and/or can combined with an animal feed component to form an animal feed composition. Use of such compositions can improve the well being of an animal, and may augment or even replace the use of antibiotics in certain circumstances.
Type:
Grant
Filed:
February 22, 2013
Date of Patent:
April 23, 2019
Assignee:
KEMIN INDUSTRIES, INC.
Inventors:
Jeffrey Richard LeBrun, Robert Levine, Geoffrey Paul Horst
Abstract: A method of producing positively charged liposome vesicles for use as carriers of lipophilic molecules. A mixture of hydrogenated phospholipids, a cationic excipient and a lipophilic molecule are dissolved in a solvent to form a composition. The composition is dried to remove the solvent. The dried composition is hydrated to form liposome vesicles and optionally the liposome vesicles are homogenized to form smaller vesicles. The vesicles are useful for delivery lipophilic molecules, such as, but limited to, lutein and zeaxanthin, to ocular tissues using iontophoresis.
Abstract: A method of producing thymoquinone and/or thymohydroquinone in Monarda by growing Monarda with elevated levels of carvacrol and/or thymol in the fresh plant tissue and vigorous growth, harvesting the Monarda, leaving the Monarda to senesce in the presence of oxygen and extracting the thymoquinone and/or thymohydroquinone from the senesced tissue.
Type:
Grant
Filed:
July 11, 2017
Date of Patent:
November 27, 2018
Assignee:
KEMIN INDUSTRIES, INC.
Inventors:
John A. Greaves, Brindha Narasimhamoorthy, Vandana Srivastava, Norman Cloud, Dawn Clark
Abstract: Immune function of a plant can be modulated by administering a composition comprising beta glucan, where the beta glucan includes unbranched beta-(1,3)-glucan. Such unbranched beta-(1,3)-glucan can be obtained from Euglena, including heterotrophically grown Euglena. The unbranched beta-(1,3)-glucan can be in the form of paramylon and/or can be part of algae meal. The composition can further include a fertilizer, a pesticide, a fungicide, a bactericide, combinations thereof, as well as one or more various plant immune system modulators other than beta glucan. The wellbeing of the plant seed, seedling, mature plant, or harvested plant product can accordingly be improved.
Type:
Grant
Filed:
March 14, 2014
Date of Patent:
November 20, 2018
Assignee:
KEMIN INDUSTRIES, INC.
Inventors:
Robert B. Levine, Geoffrey P. Horst, Jeffrey R. LeBrun
Abstract: The present invention relates to the application of beta zeolite in animal feed as a toxin binder. The beta zeolites, which contain 12 membered ring systems with Bronsted and Lewis acidic sites, have high binding efficacy against common toxins present in animal feed. This study aimed to evaluate the binding efficacy of the disclosed H beta zeolite (HBZ) has high binding efficiecy against major mycotoxins such as aflatoxin B1, ochratoxin A (OTA), zearalenone, mycophenolic acid, cyclopiazonic acid, Fumonisin B1, T-2 and patulin.
Abstract: The present invention relates to the application of beta zeolite in either a NH4+ or H+ form to animal feed as a toxin binder, wherein the beta zeolite is effective at binding pesticides commonly present in animal feed.
Abstract: A method of forming a granule having an internal three-dimensional framework of channels to control and sustain the release of an active ingredient for enteric delivery of the active ingredient in an animal fed the granule. In the composition of the granules hydrogenated vegetable oil, HVO for example, is combined with a modifier to create a granule with channels through which the active ingredient is released. The active ingredients, including but not limited to metal salts of butyric acid, can be released in the lower gut of the animal where it will best benefit the animal. By adjusting the amount of the modifier, the release rate of the active can be adjusted to suit the passage rate of the species of animal being fed.
Type:
Grant
Filed:
June 30, 2016
Date of Patent:
January 16, 2018
Assignee:
KEMIN INDUSTRIES, INC.
Inventors:
Mitchell Poss, Thoai Pham, David Sanders, Jon Rubach, Shulin Feng